Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Endothelial glycocalyx injury in bacterial bloodstream infection: biological determinants and association with host response aberrations.

Frontiers in cellular and infection microbiology·2026

Same author

Host response signatures across sepsis aetiologies in India: a single centre observational study.

The Lancet regional health. Southeast Asia·2026

Same author

Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial.

The Lancet. Respiratory medicine·2026

Same author

Editorial: The impact of proteomics on understanding inflammatory and infectious diseases.

Frontiers in immunology·2026

Same author

Endothelial glycocalyx degradation and its association with clinical outcomes and host response aberrations in community-acquired pneumonia across different care settings.

Critical care (London, England)·2026

Same author

Highly Repeatable Tissue Proteomics for Kidney Transplant Pathology: Technical and Biological Validation of Protein Analysis Using Liquid Chromatography-Tandem Mass Spectrometry/Mass Spectrometry (LC-MS/MS).

Laboratory investigation; a journal of technical methods and pathology·2026

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Precision-guided immunomodulatory therapy in sepsis - Authors' reply

Erik H A Michels¹, Hessel Peters-Sengers², Tom van der Poll³

¹Center of Infection and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

The Lancet. Respiratory Medicine

|June 17, 2026

Summary

No abstract available in PubMed .

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Related Experiment Videos

Last Updated: Jun 19, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025